Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 4 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 6Unknown 2Terminated 2Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 2Neoplasms 2

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Lidocaine × Clear all
NCT02137954 2015-08-28

LIDOSP

Assistance Publique Hopitaux De Marseille

Phase 3 Unknown
200 enrolled

Neoplasms, Pain

NCT00181012 2007-09-19

Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown
100 enrolled

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡